Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 204S204 trades$51.20M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
ADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 0 | Riley JanelChief Accounting Officer | NETCloudflare, Inc. Option exercise · 10b5-1 plan | M | — 1,667 sh | Aug 19, 2026 |
| 0 | Ashish AroraDirector, Chief Executive Officer, 10% Owner |  CRCTCricut, Inc.Derivative conversion · 10b5-1 plan | C | — 1.75M sh | Aug 19, 2026 traded Aug 19, 2026 |
| 0 | Song EstherSee Remarks |  SYNASYNAPTICS IncTax withholding · 10b5-1 plan | F | $107K 972 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Gupta VikramSee Remarks | SYNASYNAPTICS Inc Grant or award · 10b5-1 plan | A | — 34.6K sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Ellenbogen MichaelDirector |  EVLVEvolv Technologies Holdings, Inc.Option exercise · 10b5-1 plan | M | — 80.8K sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Starzak Alissa MichelleChief Legal Officer | NETCloudflare, Inc. Option exercise · 10b5-1 plan | M | — 3,333 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Hamady Robert RamseyChief Financial Officer |  SMRNUSCALE POWER CorpOption exercise · 10b5-1 plan | M | — 20.0K sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Doyle MittieChief Medical Officer |  AVTXAvalo Therapeutics, Inc.Option exercise · 10b5-1 plan | M | — 1,000 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Sullivan Christopher RyanChief Financial Officer | AVTXAvalo Therapeutics, Inc. Option exercise · 10b5-1 plan | M | $28K 2,876 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Sullivan Christopher RyanChief Financial Officer | AVTXAvalo Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 31.0K sh | Aug 19, 2026 traded Aug 18, 2026 |
| 0 | Ashish AroraDirector, Chief Executive Officer, 10% Owner | CRCTCricut, Inc. Derivative conversion · 10b5-1 plan | C | — 1.75M sh | Aug 19, 2026 traded Aug 19, 2026 |
| 0 | Sullivan Christopher RyanChief Financial Officer | AVTXAvalo Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 2,876 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Doyle MittieChief Medical Officer | AVTXAvalo Therapeutics, Inc. Option exercise · 10b5-1 plan | M | $13K 1,000 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Lin XichenCHIEF SCIENTIFIC OFFICER |  GPCRStructure Therapeutics Inc.Derivative conversion · 10b5-1 plan | C | — 3,939 sh | Aug 19, 2026 traded Aug 18, 2026 |
| 0 | Hamady Robert RamseyChief Financial Officer | SMRNUSCALE POWER Corp Option exercise · 10b5-1 plan | M | $0 0 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Ellenbogen MichaelDirector | EVLVEvolv Technologies Holdings, Inc. Option exercise · 10b5-1 plan | M | $19K 80.8K sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Lin XichenCHIEF SCIENTIFIC OFFICER | GPCRStructure Therapeutics Inc. Option exercise · 10b5-1 plan | M | $4,018 11.8K sh | Aug 19, 2026 traded Aug 18, 2026 |
| 0 | Song EstherSee Remarks | SYNASYNAPTICS Inc Grant or award · 10b5-1 plan | A | — 4,711 sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Gupta VikramSee Remarks | SYNASYNAPTICS Inc Grant or award · 10b5-1 plan | A | — 15.3K sh | Aug 19, 2026 traded Aug 17, 2026 |
| 0 | Sullivan Christopher RyanChief Financial Officer | AVTXAvalo Therapeutics, Inc. Option exercise · 10b5-1 plan | M | — 37.9K sh | Aug 19, 2026 traded Aug 17, 2026 |
| 58 | Musser ForySenior VP, Development |  VGVenture Global, Inc.Open-market sale | SELL | $6.27M 447.5K sh | Aug 18, 2026 traded Aug 14, 2026 |
| 55 | Poletti Samuel JonasChief Strategy & M&A Officer |  AMRZAmrize LtdOpen-market purchase | BUY | $118K 2,510 sh | Aug 18, 2026 traded Aug 17, 2026 |
| 55 | Musser ForySenior VP, Development | VGVenture Global, Inc. Open-market sale | SELL | $309K 22.0K sh | Aug 18, 2026 traded Aug 17, 2026 |
| 53 | PM Alpha II DAC10% Owner |  AB-LENDAB Private Lending FundOpen-market purchase | BUY | $1.33M 53.1K sh | Aug 18, 2026 traded Mar 2, 2026 |
| 49 | Chandrashekar LavanyaChief Financial Officer |  NWSNEWS CORPOpen-market sale | SELL | $510K 17.8K sh | Aug 18, 2026 traded Aug 17, 2026 |
| 49 | Allen RuthChief Human Resources Officer | NWSNEWS CORP Open-market sale | SELL | $624K 21.5K sh | Aug 18, 2026 traded Aug 17, 2026 |
| 46 | Delany JulianChief Technology Officer | NWSNEWS CORP Open-market sale | SELL | $50K 1,747 sh | Aug 18, 2026 traded Aug 17, 2026 |
| 45 | Mehta Amit AshvinSVP, Strategy & Business Ops |  REZIRESIDEO TECHNOLOGIES, INC.Open-market purchase | BUY | $226K 10.9K sh | Aug 18, 2026 traded Aug 17, 2026 |
| 44 | Kuhl HenrikDirector | EVLVEvolv Technologies Holdings, Inc. Open-market purchase | BUY | $86K 15.0K sh | Aug 18, 2026 traded Aug 14, 2026 |
| 41 | Haznedar Carolann IDirector |  NVRIEnviri CorpOpen-market purchase | BUY | $100K 4,875 sh | Aug 18, 2026 traded Aug 17, 2026 |
| 40 | Sbragia JohnSVP, Engineering and Quality |  GATXGATX CORPOpen-market sale | SELL | $343K 1,900 sh | Aug 18, 2026 traded Aug 14, 2026 |
| 40 | Hixon DylanDirector |  NRGVEnergy Vault Holdings, Inc.Open-market purchase | BUY | $107K 27.5K sh | Aug 18, 2026 traded Aug 17, 2026 |
| 39 | Beatty Jonathan SMD, Head of Advisor Services |  SCHWSCHWAB CHARLES CORPOpen-market sale | SELL | $111K 1,000 sh | Aug 18, 2026 traded Aug 17, 2026 |
| 38 | Zawitz DavidChief Operating Officer |  VRCAVerrica Pharmaceuticals Inc.Open-market purchase | BUY | $30K 6,000 sh | Aug 18, 2026 traded Aug 17, 2026 |
| 38 | Atalioti AthinaChief Financial Officer |  EHLDEuroholdings Ltd.Open-market sale | SELL | $3,000 300 sh | Aug 18, 2026 traded Aug 17, 2026 |
| 38 | Lentell EricChief Legal & Strategy Officer |  ACHRArcher Aviation Inc.Open-market sale | SELL | $338K 52.8K sh | Aug 18, 2026 traded Aug 17, 2026 |
| 37 | Rieger JaysonDirector, CEO and President | VRCAVerrica Pharmaceuticals Inc. Open-market purchase | BUY | $101K 20.0K sh | Aug 18, 2026 traded Aug 14, 2026 |
| 37 | O'Neill ShivGC AND CORP SEC |  ELANElanco Animal Health IncOpen-market purchase | BUY | $94K 3,998 sh | Aug 18, 2026 traded Aug 18, 2026 |
| 37 | Plakantonaki CharisChief Strategy Officer |  SBLKStar Bulk Carriers Corp.Open-market sale | SELL | $313K 10.8K sh | Aug 18, 2026 traded Aug 14, 2026 |
| 36 | Dewan SameerSenior Vice President |  GGenpact LTDOpen-market sale | SELL | $454K 13.3K sh | Aug 18, 2026 traded Aug 14, 2026 |